GSK Says Paper Published In Nature Medicine By Company Scientists To Be Retracted
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK confirms dismissal of R&D China Head Jingwu Zang. GSK internal communication seen by PharmAsia News alleges “disturbing efforts” by employees to undermine an internal investigation into a paper on preclinical research; GSK suspends programs related to IL-7 receptor signaling pathway.